SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Filana Therapeutics, Inc. (NASDAQ:FLNA)

US · Delayed Price · Currency is USD
0.64-0.02 (-2.84%)
 
Market Cap30.70M-69.0%
Revenue (ttm)0
Net Income-42.28M+65.7%
EPS-0.87+65.9%
Shares Out48.31M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume311,105
Open0.64
Previous Close0.65
Day's Range0.62 - 0.65
52-Week Range0.62 - 3.94
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateOct 29, 2026
-2.16% (1D)
No price history available.
Insider Score
/ 100
FLNA Insider Score

FILANA THERAPEUTICS, INC. has a live Insider Score.

Scored on 3 qualifying trades from 1 insider in the last 90 days.

Unlock the score

About FLNA

Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.

Address
6801 N. Capital of Texas Highway, Austin, TX, 78731, US
Market Cap
31 million
Employees
19
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$997.08K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-2.84%
5 Days
-9.86%
1 Month
-15.05%
6 Months
-60.53%
1 Year
-69.00%

$FLNA stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in FLNA holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by FLNA's directors and management

Net Shares Purchased by Insiders−400k−200k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

FLNA Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New FLNA patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to FLNA from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in FLNA

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$1.21M
VXFVanguard Extended Market ETF$499.60K
VHTVanguard Health Care ETF$119.02K
IWCiShares Micro-Cap ETF$95.66K

Estimated from each fund’s disclosed top holdings × AUM

FLNA Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for FLNA is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from FLNA’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
6
Sells
0
Buy Value
$997.08K
Distinct Buyers
2

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.